Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | transcription factor 7-like 2 (T-cell specific, HMG-box) | References | |
Homo sapiens | catenin (cadherin-associated protein), beta 1, 88kDa | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Armadillo/beta-catenin-like repeat family protein | 0.0116 | 0.0031 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0281 | 0.6851 | 1 |
Echinococcus multilocularis | beta catenin | 0.0116 | 0.0031 | 0.5 |
Loa Loa (eye worm) | HMP-2 protein | 0.0116 | 0.0031 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 13 uM | Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein labeled human wild-type Tcf4 (residues 7-51) interaction after 1.5 hrs by FP competitive inhibition assay | ChEMBL. | 25985283 |
IC50 (binding) | = 300 uM | Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein-labeled human E-cadherin (residues 819-873) interaction by FP competitive inhibition assay | ChEMBL. | 25985283 |
IC50 (binding) | = 350 uM | Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein-labeled human APC-R3 (residues 1477-1519) interaction by FP competitive inhibition assay | ChEMBL. | 25985283 |
Ki (binding) | = 3.1 uM | Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein labeled human wild-type Tcf4 (residues 7-51) interaction after 1.5 hrs by FP competitive inhibition assay | ChEMBL. | 25985283 |
Ki (binding) | = 3.1 uM | Inhibition of human beta-casein/Tcf4 interaction after 1 hr by fluorescence polarization assay | ChEMBL. | 24900664 |
Ki (binding) | = 3.14 uM | Competitive binding affinity to human beta-catenin (142 to 686) assessed as inhibition of C-terminally fluorescein-labeled Tcf4 interaction after 3 hrs by fluorescence polarization assay | ChEMBL. | 24751445 |
Ki (binding) | = 3.8 uM | Inhibition of N-terminally His6-tagged human beta-catenin (residues 138-686)/C-terminally biotinylated human Tcf4 (residues 7-51) interaction after 45 mins by AlphaScreen competitive inhibition assay | ChEMBL. | 25985283 |
Ki (binding) | = 3.8 uM | Inhibition of human beta-casein/Tcf4 interaction after 1 hr by alphascreen assay | ChEMBL. | 24900664 |
Ki (binding) | = 170 uM | Inhibition of human beta-casein/APC-R3 interaction after 1 hr by alphascreen assay | ChEMBL. | 24900664 |
Ki (binding) | = 180 uM | Inhibition of human beta-casein/APC-R3 interaction after 1 hr by fluorescence polarization assay | ChEMBL. | 24900664 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.